Skip to main content
NEWS & EVENTS

Keep up to date with all of our latest news and events

Use the filters to find Publications, Featured News, Clinical Trials and more.

LATEST NEWS

Filter

November 17, 2023

Outstanding 12-month first-in-human data from Xeltis’ aXess hemodialysis vascular conduit trial presented at VEITHsymposium 2023

aXess demonstrated exceptional patency rates and no infections to date Xeltis, a leading developer of transformative implants that enable the…

Press Releases

Xeltis starts pivotal clinical trial with first ever restorative synthetic hemodialysis access graft

EN

Xeltis presents promising FIH data on restorative hemodialysis access graft at ESVS congress

EN

Xeltis receives commitment from Grand Pharma to invest €15M

EN

Xeltis lands €15 million European financing from EIB

ENNL

Xeltis initiates first-ever pivotal trial of a synthetic restorative pulmonary heart valve

EN

Media

ETR Powered Platform

Endogenous Tissue Restoration Animation

Pulmonary Heart Valve

Endogenous Tissue Restoration Animation

Prof. Mauro Gargiulo

The aXess EU Pivotal Trial

Professor Thierry Carrel

Xeltis’ technology

Martijn Cox

Xeltis’ Co-founder on ETR

Professor Jean-Marie Lehn

Nobel Laureate Professor Lehn visits Xeltis

A Patient’s Perspective

An interview with Stefan

Global Impact of Heart Valve Disease

Professor Christian M. Spaulding